Table 1 Baseline data of 60 patients undergoing cardioneuroablation.
From: Safety and efficacy of cardioneuroablation for vagal bradycardia in a single arm prospective study
Index | Numerical value |
|---|---|
Number of patients [n (%)] | 60 (100.00%) |
Male [n (%)] | 38 (63.33%) |
Age (years, Mean ± SD) | 36.67 ± 9.44 |
BMI(kg/m2 Mean ± SD) | 23.83 ± 4.47 |
Atropine tests were positive [n (%)] | 60 (100%) |
Type of bradycardia [n (%)] | |
 Sinus arrest | 28 (46.67%) |
 Sinus bradycardia | 13 (21.67%) |
 Intermittent high atrioventricular block at night | 9 (15.00%) |
 Intermittent high atrioventricular block at night + sinus arrest | 7 (11.67%) |
 Sinus arrest + sinus bradycardia | 3 (5.00%) |
Clinical symptoms [n (%)] | |
 Amaurosis | 21 (35.00%) |
 Syncope | 39 (65.00%) |
 Follow-up time (days, Mean ± SD) | 368.15 ± 7.26 |
